21st Feb 2008 12:19
Skyepharma PLC21 February 2008 SkyePharma to Announce Preliminary Results on 27 March LONDON, UK, 21 February 2008 - SkyePharma PLC (LSE: SKP) announces that it willissue its preliminary results for the year ended 31 December 2007 to the LondonStock Exchange at 7:00 a.m. on Thursday 27 March 2008. An analyst briefing will be given by Frank Condella (CEO), Dr Ken Cunningham(COO) and Peter Grant (Finance Director) at the London offices of FinancialDynamics at 9.00 a.m. and will be webcast live (audio and presentation only).Investors and other interested parties may listen to the live webcast via theCompany's website at www.skyepharma.com under the Investor Relations tab. For further information, please contact: SkyePharma PLC Frank Condella +44 20 7491 1777During office hours Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113Outside office hours Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has twelve approved products in the areas of oral,inhalation and topical delivery. The Group's products are marketed throughoutthe world by leading pharmaceutical companies. For more information, visitwww.skyepharma.com Note to Analysts Please call Mo Noonan for further details of the presentation on 020 7269 7116or email [email protected]. Analysts may prefer to participate in thepresentation by conference call. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L